NO20015519L - Pharmaceutical composition comprising apocodein and / or its derivatives - Google Patents

Pharmaceutical composition comprising apocodein and / or its derivatives

Info

Publication number
NO20015519L
NO20015519L NO20015519A NO20015519A NO20015519L NO 20015519 L NO20015519 L NO 20015519L NO 20015519 A NO20015519 A NO 20015519A NO 20015519 A NO20015519 A NO 20015519A NO 20015519 L NO20015519 L NO 20015519L
Authority
NO
Norway
Prior art keywords
apocodein
derivatives
pharmaceutical composition
male
apc
Prior art date
Application number
NO20015519A
Other languages
Norwegian (no)
Other versions
NO20015519D0 (en
Inventor
Mario Baraldi
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Publication of NO20015519D0 publication Critical patent/NO20015519D0/en
Publication of NO20015519L publication Critical patent/NO20015519L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Tre farmasøytiske sammensetninger er beskrevet; sakte-frigivelsestransdermale plaster, sublinguale/tyggbare tabletter og spray basert på apokodein (APC) og/eller dets derivater, for behandlingen av mannlig impotens og for sti- muleringen av mannlig og kvinnelig libido.Three pharmaceutical compositions are described; slow-release transdermal patches, sublingual / chewable tablets and apocodein (APC) and / or its derivatives sprays, for the treatment of male impotence and for the stimulation of male and female libido.

NO20015519A 1999-05-13 2001-11-12 Pharmaceutical composition comprising apocodein and / or its derivatives NO20015519L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE990389 1999-05-13
PCT/IE2000/000065 WO2000069416A1 (en) 1999-05-13 2000-05-12 Pharmaceutical compositions comprising apocodeine and/or its derivatives

Publications (2)

Publication Number Publication Date
NO20015519D0 NO20015519D0 (en) 2001-11-12
NO20015519L true NO20015519L (en) 2002-01-11

Family

ID=11042062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015519A NO20015519L (en) 1999-05-13 2001-11-12 Pharmaceutical composition comprising apocodein and / or its derivatives

Country Status (7)

Country Link
EP (1) EP1175206A1 (en)
JP (1) JP2002544221A (en)
AU (1) AU4427000A (en)
CA (1) CA2371551A1 (en)
MX (1) MXPA01011480A (en)
NO (1) NO20015519L (en)
WO (1) WO2000069416A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02009904A (en) * 2000-04-07 2004-09-06 Tap Pharmaceutical Prod Inc Apomorphine derivatives and methods for their use.
SE0002934D0 (en) 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
FI873429A7 (en) * 1986-08-18 1988-02-19 Houston Biotechnology Incorporated Ophthalmic compositions for the treatment of neural degenerations.
DE69709646T2 (en) * 1996-03-12 2002-08-14 Alza Corp., Palo Alto COMPOSITION AND DOSAGE WITH AN OPIOID ANTAGONIST

Also Published As

Publication number Publication date
MXPA01011480A (en) 2002-06-04
JP2002544221A (en) 2002-12-24
CA2371551A1 (en) 2000-11-23
EP1175206A1 (en) 2002-01-30
NO20015519D0 (en) 2001-11-12
AU4427000A (en) 2000-12-05
WO2000069416A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
IS4146A (en) A pharmaceutical preparation for oral administration of proton pump blockers
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
ATE254110T1 (en) ANTIPROLIFERATIVE IMIDAZOLE ACTIVE INGREDIENTS
DE69803360D1 (en) APPLICATION FORMS FOR TREATING MALE ERECTILE DYSFUNCTION
GB0022438D0 (en) Organic Compounds
IL139227A0 (en) N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders
WO2000056296A3 (en) Compositions for improving fertility
BG66093B1 (en) Controlled release compositions comprising nimesulide
MXPA06000302A (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
NO20035438L (en) Pharmaceutical Formulation for Effective Administration of Apomorphine, 6aR - (-) - N-Propyl-Norapomorphine and Their Derivatives and Prodrugs
TW200510392A (en) Chemical compounds
DE60019334D1 (en) ANTIVIRAL ARZNEI
HUP0401811A2 (en) Medicinal composition improved in solubility in water and process for its preparation
CY1107819T1 (en) PHARMACEUTICAL FORM OF OLANZAPIN
TW200505452A (en) Chemical compounds
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
BR0007452A (en) Use of melagatran or a pharmaceutically acceptable derivative or prodrug thereof, method of treating inflammation, and, pharmaceutical formulation for use in treating inflammation
UY26895A1 (en) PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS TO MODULATE AND / OR INHIBIT THE ACTIVITY OF ERAB / HADH2
DK1355906T3 (en) 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions containing them
HUP0203050A2 (en) Treating endometriosis or infertility, or improving fertility
NO20015519L (en) Pharmaceutical composition comprising apocodein and / or its derivatives
TR200302134T4 (en) Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and / or physiologically acceptable salts thereof as anti-cancer agents.
HK1045987A1 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives
NO20020914D0 (en) Alkoxy-substituted benzimidazole compounds, preparations containing them and their applications
ES2188909T3 (en) NEW DERIVATIVES OF CIS-3,4-CHROMANE USEFUL FOR THE PREVENTION OR TREATMENT OF SYNDROMES OR ILLNESS RELATED TO THE ESTROGEN. YOU

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application